praliciguat and Proteinuria

praliciguat has been researched along with Proteinuria* in 1 studies

Other Studies

1 other study(ies) available for praliciguat and Proteinuria

Article	Year
Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease. The Journal of pharmacology and experimental therapeutics, 2018, Volume: 365, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Arteries; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Fibrosis; HEK293 Cells; Humans; Kidney; Male; Mice; Nitric Oxide; Proteinuria; Pyrazoles; Pyrimidines; Rats; Signal Transduction; Soluble Guanylyl Cyclase; Tissue Distribution; Vasodilation	2018

Article

Year

Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease.

The Journal of pharmacology and experimental therapeutics, 2018, Volume: 365, Issue:3

Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Arteries; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Fibrosis; HEK293 Cells; Humans; Kidney; Male; Mice; Nitric Oxide; Proteinuria; Pyrazoles; Pyrimidines; Rats; Signal Transduction; Soluble Guanylyl Cyclase; Tissue Distribution; Vasodilation

2018